Public procurement notice: Contract Notice
Published: 2020-12-22
Buyer: Medicines Discovery Catapult
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33000000
Estimated value: 550000 GBP
Submission deadline: 2021-01-22
Award criteria: The most economic tender

Technical requirements: Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet
Medicines Discovery Catapult (MDC) are a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
This Invitation to Tender (ITT) has been issued by MDC for the establishment of a framework agreement for the supply and delivery of Covid-19 Samples for delivery to Oncimmune at the following address:
This ITT is in accordance with the Public Contracts Regulations 2015. The contract notice has been advertised in the supplement to the Official Journal of the European Union and on contracts finder. The process is being conducted under the EU Procurement Directive’s open procedure.
Tenders shall remain open for acceptance by MDC for 120 days from the tender deadline date. The purchase of Covid-19 Samples shall include the cost of collection, storage and delivery as well as any administrative requirements.
The supplier shall ensure they have measures in place to ensure the fulfilment of the contract in the event of any developments from Britain’s exit from the European Union (BREXIT). The tenderer must state in their tender submission if there are any concerns with the Tenderer fulfilling its obligations under the contract due to BREXIT. The costs quoted in the pricing schedule appendix 2 are fixed for the life of the contract and must include the costs to serve associated with the administration and management of the contract including but not limited to; all costs associated with BREXIT, and all the points in this document, the MDC contract appendix 1 and the Specification appendix 3.
The tender is for the establishment of a framework agreement for the supply and delivery of Covid-19 samples. It is intended that a maximum of six (6) suppliers will be appointed to the framework agreement. These will be the tenderers who achieve the highest total scores based on the award criteria. If a number of suppliers score equally and fall into joint sixth (6th) place, then all tenderers in equal sixth (6th) place will be awarded a place on the framework agreement.
The purchase of the Covid-19 Samples is subject to the approval of MDC funders as such the Tenderer accept and acknowledge that by issuing this tender MDC shall not be bound to accept any Tender and reserves the right not to conclude a framework agreement for the supply and delivery of Covid-19 samples for which tenders are invited.
MDC have a GBP 450 000.00 budget for the collection, supply and delivery of 3 000 Covid-19 samples under this framework agreement, however there is no guaranteed level of expenditure on this framework agreement.
If it is deemed in MDC’s best interest to not use this framework agreement, MDC shall have the right to procure samples outside of this framework agreement.
This framework agreement is for a 24-month period, with an option to extend for a further 12 months, or until such time as the requisite number of samples have been collected (whether this is a shorter period).
Tender submissions, the resulting framework agreement and any call off contracts shall be based on the MDC Contract appendix 1.
Medicines Discovery Catapult (MDC) are a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
This Invitation to Tender (ITT) has been issued by MDC for the establishment of a framework agreement for the supply and delivery of Covid-19 Samples for delivery to Oncimmune at the following address:
This ITT is in accordance with the Public Contracts Regulations 2015. The contract notice has been advertised in the supplement to the Official Journal of the European Union and on Contracts Finder. The process is being conducted under the EU Procurement Directive’s open procedure.


Award value: 550000